ReviewAnnals of biomedical engineering2025
Chemical Characterization in Medical Device Evaluation: Current Practices, Regulatory Requirements, and Future Directions.
Review in Annals of biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advanced nanobiosensors for the detection of neurovascular damage in cerebral infarction: prospects and challenges.Journal of biological engineering · 2026Article
- Green and Scalable Manufacturing of Biodegradable Polymer Scaffolds: Solvent-Free Processing, Supercritical COPolymers · 2026Review
- Advances in Silicone Implants Characterization: A Comprehensive Overview of Chemical, Physical and Biological Methods for Biocompatibility Assessment.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rigorous regulatory landscape for medical devices demands meticulous chemical characterization to ensure safety and compliance. This review examines the critical role of chemical characterization within regulatory frameworks, emphasizing its importance in the approval and market entry of medical devices. Key challenges, including the complexity of sample matrices, trace-level impurity detection, and the necessity of method validation, are thoroughly explored. In addition, the review addresses the dynamic nature of regulatory requirements, analyzing how updates in international standards, such as those from the International Organization for Standardization (ISO), the American National Standards Institute (ANSI), and the Association for the Advancement of Medical Instrumentation (AAMI), or the American Society for Testing and Materials (ASTM), shape the chemical characterization process. The review discusses future directions, including advancements in analytical technologies, the potential for increased automation and standardization, and the growing significance of managing emerging contaminants. By offering a comprehensive analysis of current practices and future trends, this review highlights the essential role of chemical characterization in ensuring the development and regulation of safe and effective medical devices.
Indexed as
Identifiers
40035968What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.